|
Myasthenia
Citations 61-67 of 67 total displayed.
|
Past content
(since Jan 2001):
|
- BRIEF COMMUNICATIONS
Spontaneous remission in canine myasthenia gravis: Implications for assessing human MG therapies
- G. Diane Shelton and Jon M. Lindstrom
Neurology 2001; 57: 2139-2141.
[Abstract]
[Full text]
[PDF]
- ARTICLES
Linkage of HLA to myasthenia gravis and genetic heterogeneity depending on anti-titin antibodies
- M. Giraud, G. Beaurain, A. M. Yamamoto, B. Eymard, C. Tranchant, P. Gajdos, and H.-J. Garchon
Neurology 2001; 57: 1555-1560.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Rapid infusion of intravenous immune globulin in patients with neuromuscular disorders
- J. A. Grillo, K. C. Gorson, A. H. Ropper, J. Lewis, and R. Weinstein
Neurology 2001; 57: 1699-1701.
[Abstract]
[Full text]
[PDF]
- CLINICAL/SCIENTIFIC NOTES
Asystole induced by edrophonium following beta blockade
- M. S. Okun, C. M. Charriez, M. T. Bhatti, R. T. Watson, and T.R. Swift
Neurology 2001; 57: 739.
[Full text]
[PDF]
- ARTICLES
Presynaptic congenital myasthenic syndrome due to quantal release deficiency
- R. A. Maselli, D. Z. Kong, C. M. Bowe, C. M. McDonald, W. G. Ellis, M. A. Agius, C. M. Gomez, D. P. Richman, and R. L. Wollmann
Neurology 2001; 57: 279-289.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Mycophenolate mofetil: A safe and promising immunosuppressant in neuromuscular diseases
- V. Chaudhry, D. R. Cornblath, J. W. Griffin, R. O’Brien, and D. B. Drachman
Neurology 2001; 56: 94-96.
[Abstract]
[Full text]
[PDF]
- BRIEF COMMUNICATIONS
Mycophenolate mofetil for myasthenia gravis: An open-label pilot study
- E. Ciafaloni, J.M. Massey, B. Tucker–Lipscomb, and D.B. Sanders
Neurology 2001; 56: 97-99.
[Abstract]
[Full text]
[PDF]
|
|
